<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine</rel_title>
    <rel_doi>10.1101/2020.02.17.951939</rel_doi>
    <rel_link>http://biorxiv.org/cgi/content/short/2020.02.17.951939</rel_link>
    <rel_abs>A recombinant adenovirus vaccine against the SARS Coronavirus (SARS-CoV) was constructed, which contains fragments from the S, N, and Orf8 genes. Rhesus Macaques immunized with the recombinant adenovirus generated antigen-specific humoral and cellular response. Furthermore, the vaccine provided significant protection against subsequent live SARS-CoV challenge. In contrast, three out of four monkeys immunized with placebo suffered severe alveolar damage and pulmonary destruction.</rel_abs>
    <rel_authors>Chen, Y.; Qin, C.; Wei, Q.; Li, R.; Gao, H.; Zhu, H.; Deng, W.; Bao, L.; Wei, T.</rel_authors>
    <rel_date>2020-02-21</rel_date>
    <rel_site>biorxiv</rel_site>
</item>